Xylocaine 1% (50mg/5mL) ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

xylocaine 1% (50mg/5ml) ampoule

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride; sodium hydroxide - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block.

Xylocaine 2.0% 40mg/2mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

xylocaine 2.0% 40mg/2ml injection ampoule

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 20 mg/ml - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques; infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block

Xylocaine 1% (20mg/2mL) ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

xylocaine 1% (20mg/2ml) ampoule

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride; sodium hydroxide - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques; infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block

Xylocaine Australia - English - Department of Health (Therapeutic Goods Administration)

xylocaine

astrazeneca pty ltd - lignocaine hydrochloride anhydrous; adrenaline acid tartrate; lignocaine hydrochloride -

2% LIGNOCAINE WITH ADRENALINE 1-100,000 LOCAL ANAESTHETIC INJECTION Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

2% lignocaine with adrenaline 1-100,000 local anaesthetic injection

troy laboratories pty ltd - lignocaine hydrochloride | adrenaline tartrate - anaesthetics/analgesics - cat | cattle | dog | horse | pigs | sheep | beef | bitch | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | - anaesthetic - local/general | general anaesthetic | immobiliser | local anaesthetic | premedication | sedative | tranquilliser | travel sickness

2% LIGNOCAINE WITH ADRENALINE 1-100000 LOCAL ANAESTHETIC STERILE INJECTION Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

2% lignocaine with adrenaline 1-100000 local anaesthetic sterile injection

troy laboratories pty ltd - lignocaine hydrochloride | adrenaline tartrate - anaesthetics/analgesics - cat | cattle | dog | horse | pigs | sheep | beef | bitch | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | - not applicable (vet)

Adrenaline (base) for anaphylaxis 1mg/1ml (1 in 1,000) solution for injection pre-filled syringes United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

adrenaline (base) for anaphylaxis 1mg/1ml (1 in 1,000) solution for injection pre-filled syringes

base) for anaphylaxis 1mg/1ml (1 in 1,000) solution for injection pre-filled syringes (martindale pharmaceuticals ltd - adrenaline - solution for injection - 1mg/1ml

3% CITANEST DENTAL WITH ADRENALINE 1:300,000 2.2mL injection cartridge Australia - English - Department of Health (Therapeutic Goods Administration)

3% citanest dental with adrenaline 1:300,000 2.2ml injection cartridge

dentsply sirona pty ltd - prilocaine hydrochloride, quantity: 30 mg/ml; adrenaline (epinephrine) acid tartrate, quantity: 0.0061 mg/ml - injection, solution - excipient ingredients: sodium chloride; sodium metabisulfite; water for injections; hydrochloric acid; sodium hydroxide - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) indications as at 14 july 2003 : citanest is indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques.

0.5% MARCAIN DENTAL with ADRENALINE 1:200,000 2.2mL injection cartridge Australia - English - Department of Health (Therapeutic Goods Administration)

0.5% marcain dental with adrenaline 1:200,000 2.2ml injection cartridge

dentsply sirona pty ltd - bupivacaine hydrochloride monohydrate, quantity: 5 mg/ml; adrenaline (epinephrine) acid tartrate, quantity: 9.1 microgram/ml (equivalent: adrenaline (epinephrine), qty 5 microgram/ml) - injection, solution - excipient ingredients: sodium metabisulfite; sodium chloride; water for injections; hydrochloric acid; sodium hydroxide - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) 0.5% marcain dental with adrenaline 1:200,000 is indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques.

Lignocaine and Adrenaline Egypt - English - EDA (Egyptian Drug Authority)

lignocaine and adrenaline

egavet - lignocaine hydrochloride 20 mg + adrenaline acid tartarate 0.0227 mg ( eq. to 0.0125 mg adrenaline base ) /1ml - solution for injection